Lee's Pharmaceutical Holdings Limited (0950.HK)
HKD 1.37
(-0.72%)
HKD 1.37
(-0.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.05 Billion | 1.23 Billion | 1.26 Billion | 1.21 Billion | 1.21 Billion | 1.13 Billion |
| Cost of Revenue | 501.72 Million | 462.39 Million | 459.87 Million | 435.65 Million | 420.65 Million | 391.25 Million |
| Gross Profit | 551.31 Million | 770.75 Million | 806.28 Million | 781.06 Million | 798.25 Million | 746.37 Million |
| Operating Expenses | 590.99 Million | 694.48 Million | 889.38 Million | 691.18 Million | 611.3 Million | 549.66 Million |
| Selling, General and Administrative Expenses | 494.18 Million | 544.88 Million | 663.7 Million | 517.66 Million | 490.84 Million | 410.66 Million |
| Research and Development Expenses | 96.8 Million | 168.88 Million | 243.83 Million | 203.29 Million | 149.94 Million | 153.17 Million |
| Other Expenses | - | -19.27 Million | -18.15 Million | -29.77 Million | -29.49 Million | -14.17 Million |
| Cost and Expenses | 1.09 Billion | 1.15 Billion | 1.34 Billion | 1.12 Billion | 1.03 Billion | 940.92 Million |
| Operating Income | 36.04 Million | 123.01 Million | -694 Thousand | 151.92 Million | 244.59 Million | 466.93 Million |
| Interest Expense | 11.89 Million | 6.61 Million | 4.4 Million | 5.38 Million | 5.75 Million | 4.16 Million |
| Income Tax Expense | 10.83 Million | 22.02 Million | 9.48 Million | 55.5 Million | 59.54 Million | 56.62 Million |
| Earnings before Tax | 30.78 Million | 67.86 Million | 1.96 Billion | 134.03 Million | 122.88 Million | 446.38 Million |
| Net Income | 16.69 Million | 51.28 Million | 1.98 Billion | 78.53 Million | 63.34 Million | 418.26 Million |
| Earnings Per Share Basic | 0.03 | 0.09 | 3.38 | 0.13 | 0.11 | 0.71 |
| Earnings Per Share Diluted | 0.03 | 0.09 | 3.37 | 0.13 | 0.11 | 0.70 |
| Weighted Average Shares Outstanding | 588.83 Million | 588.83 Million | 588.64 Million | 588.12 Million | 591.57 Million | 591.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 588.83 Million | 588.83 Million | 589.04 Million | 588.16 Million | 591.88 Million | 595.15 Million |
| Gross Margin | 0.52 | 0.63 | 0.64 | 0.64 | 0.65 | 0.66 |
| EBIT Margin | 0.10 | 0.22 | 0.12 | 0.23 | 0.28 | 0.46 |
| Profit Margin | 0.02 | 0.04 | 1.57 | 0.06 | 0.05 | 0.37 |
| EBITDA | 109.82 Million | 229.05 Million | 2.12 Billion | 279.42 Million | 235.54 Million | 516.17 Million |
| Earnings Before Tax Margin | 0.03 | 0.10 | -0.00 | 0.12 | 0.20 | 0.41 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.05 Billion | 270.36 Million | 270.36 Million | 256.15 Million | 256.15 Million | 1.23 Billion |
| Cost of Revenue | 501.72 Million | 136.93 Million | 136.93 Million | 113.92 Million | 113.92 Million | 462.39 Million |
| Gross Profit | 551.31 Million | 133.42 Million | 133.42 Million | 142.23 Million | 142.23 Million | 770.75 Million |
| Operating Expenses | 590.99 Million | 128.9 Million | 128.9 Million | 126.49 Million | 126.49 Million | 694.48 Million |
| Selling, General and Administrative Expenses | - | 128.18 Million | 128.18 Million | 118.9 Million | 118.9 Million | - |
| Research and Development Expenses | - | 44.77 Million | 44.77 Million | 24.39 Million | 24.39 Million | - |
| Other Expenses | 43.4 Million | - | - | - | - | -19.27 Million |
| Cost and Expenses | 1.09 Billion | 265.83 Million | 265.83 Million | 240.41 Million | 240.41 Million | 1.15 Billion |
| Operating Income | -39.68 Million | 1.81 Million | 1.81 Million | 16.2 Million | 16.2 Million | 123.01 Million |
| Interest Expense | 11.27 Million | 6.45 Million | - | 5.43 Million | - | 6.61 Million |
| Income Tax Expense | 10.83 Million | 2.27 Million | 2.27 Million | 3.13 Million | 3.13 Million | 22.02 Million |
| Earnings before Tax | 31.65 Million | 1.79 Million | 1.79 Million | 13.59 Million | 13.59 Million | 67.86 Million |
| Net Income | 16.69 Million | 290.5 Thousand | 290.5 Thousand | 8.05 Million | 8.05 Million | 51.28 Million |
| Earnings Per Share Basic | - | 0.00 | 0.00 | 0.01 | 0.01 | - |
| Earnings Per Share Diluted | - | 0.00 | 0.00 | 0.01 | 0.01 | - |
| Weighted Average Shares Outstanding | 588.83 Million | 589.24 Million | 589.24 Million | 588.85 Million | 588.85 Million | 588.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 588.83 Million | 588.83 Million | 588.83 Million | 588.83 Million | 588.83 Million | 588.83 Million |
| Gross Margin | 0.52 | 0.49 | 0.49 | 0.56 | 0.56 | 0.63 |
| EBIT Margin | - | 0.04 | 0.04 | 0.22 | 0.22 | - |
| Profit Margin | 0.02 | 0.00 | 0.00 | 0.03 | 0.03 | 0.04 |
| EBITDA | - | 10.23 Million | 10.23 Million | 55.07 Million | 55.07 Million | - |
| Earnings Before Tax Margin | -0.04 | 0.01 | 0.01 | 0.06 | 0.06 | 0.10 |
SAPR3
3705
PLUS
THRM
PEMSF
5269